Skip to main content
. 2013 Feb 5;75(3):779–790. doi: 10.1111/j.1365-2125.2012.04386.x

Figure 1.

Figure 1

Pharmacokineticsof GSK2190915. Mean plasma concentration vs. time profiles for GSK2190915 in healthy Western European subjects on (A) day 1 after single dose administration of 50 mg, (Inline graphic), 150 mg (Inline graphic), 300 mg (Inline graphic), 600 mg (Inline graphic) or 1000 (Inline graphic) mg. Mean plasma concentration vs. time profiles for GSK2190915 in healthy Western European subjects on (B) day 1 or (C) day 11 following multiple dose administration of 10 mg (Inline graphic), 50 mg, (Inline graphic), 150 mg (Inline graphic) or 450 mg (Inline graphic).